shine-logo

SHINE, EDH enter distribution agreement for SHINE’s non-carrier-added Lu-177

SHINE Medical Technologies LLC today announced that they have entered into a distribution agreement enabling EDH to act as a SHINE-authorized distributor for selected countries

2021-12-17T17:36:27-06:00May 25, 2021|2021, Medical Isotopes, News, News Releases, Therapeutics|

SHINE selects Netherlands for European isotope production facility

SHINE Medical Technologies LLC today announced that it has selected the municipality of Veendam in the province of Groningen, the Netherlands, as the location of its European medical isotope production facility. The decision is the culmination of a year-long search process that included the review of more than 50 proposals from sites across Europe.

2021-12-17T17:36:40-06:00May 19, 2021|2021, Medical Isotopes, News|

SHINE announces first sales of n.c.a. Lu-177

SHINE announced that its Therapeutics division has made its first commercial sales of lutetium-177 to multiple customers. Lutetium-177, or Lu-177, is a therapeutic isotope in demand by clinical trial sponsors because of its potential to revolutionize the treatment of cancer patients.

2021-12-17T17:38:58-06:00November 4, 2020|2020, Medical Isotopes, News, News Releases, Therapeutics|

SHINE & IOCB deliver Lu-177 doses to GE

SHINE Medical Technologies LLC, the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and GE Healthcare today announced the production of patient doses of the therapeutic isotope lutetium-177 (Lu-177).

2021-12-16T20:07:30-06:00January 21, 2020|2020, Medical Isotopes, News, News Releases, Therapeutics|

SHINE Creates Therapeutics Division

SHINE Medical Technologies today announced the creation of a new division of the company — SHINE Therapeutics. The establishment of the division enhances the company’s ability to focus on filling critical future needs in the rapidly growing therapeutic isotope market, while continuing to leverage its radioisotope production expertise.

2021-12-17T17:41:45-06:00October 11, 2019|2019, Archived, Medical Isotopes, News Releases|
Go to Top